These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells. Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline. Han L; Song N; Hu X; Zhu A; Wei X; Liu J; Yuan S; Mao W; Chen X Life Sci; 2020 Apr; 246():117419. PubMed ID: 32045592 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin S promotes the development of pulmonary arterial hypertension. Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016 [TBL] [Abstract][Full Text] [Related]
20. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension. Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]